TNYA Award Disclosure
Ali Faraz · SEC Form 4 · Filed Sep 11, 2026
Award
Calculated transaction value
$0
Ali Faraz Chief Executive Officer
TNYA
Tenaya Therapeutics
TNYA
Transaction date
Sep 10, 2026
Public filing date
Sep 12, 2026
Filing lag
Filed 2 days later
TNYA daily price context
Close on/before transaction
$0.65
Sep 10, 2026
Close before public filing
$0.65
Sep 11, 2026
Return since public filing
0.0%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 122,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-389563
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Tenaya Therapeutics, Inc. TNYA Current | Award | Sep 10, 2026 | $0 |
| Tenaya Therapeutics, Inc. TNYA | Award | Sep 10, 2026 | $0 |